Cold Plasma Group (CPG) participates in programs offered by Queen's Partnerships and Innovation (QPI), that have been made possible with support from the Government of Canada through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) via the ScaleUp Platform Project, the WE-CAN (Women Entrepreneurs Can) Project, and the Health Innovation Kingston (HI YGK) Project.
The QPI team supports the university’s strategic goal to build community partnerships and fully embed Queen’s in the community. With support from external funding, the QPI team offers numerous services, resources, and programs to support entrepreneurs, both from within Queen’s University and from the greater Kingston community, and to accelerate the growth of startups and small to medium-sized enterprises within Kingston and Eastern Ontario.
“The mentorship and resources we have received from Queen’s Partnerships and Innovation over the years have helped tremendously in refining our business model, presenting our company, and getting us to this point,” says Dr. Florina Truica, Chief Technology Officer (CTO) of CPG.
Recently, CPG and GOC-NEXUS Europe GmbH issued the following MMJ Daily press release:
Partnership for commercial implementation of eco-friendly sterilization technology
Cold Plasma Group Inc. (CPG) has completed a cooperation and licensing agreement with GOC-NEXUS Europe GmbH to supply and to further scale up CPG’s plasma sterilization technology for cannabis.
CPG’s patent-pending technology gently destroys bacterial and fungal spores without altering the quality of cannabis flower nor the concentrations of cannabinoids and terpenes. CPG’s technology is eco-friendly and free of ionizing radiation, heat, or added chemicals, which makes it ideal for treating cannabis destined for the European market. CPG will supply its present third-generation machine for a demonstration facility in Canada and will develop larger-scale versions of the equipment for the exclusive use by GOC in EU-GMP processing hubs for the European and global medical markets.
“We believe we’ve found an ideal industry partner with deep roots in both medicinal cannabis and the European recreational market. We are jointly moving towards our dream of a demonstration facility in Canada aimed at the existing Canadian market and, subsequently, the American market as it legalizes,” said David Johnson, Cold Plasma Group’s President. Simultaneously, we will design and EU-GMP certify the technology on a much larger scale for Europe. GOC-NEXUS’ experience with GMP certification will accelerate the growth of plasma treatment in Europe and globally.”
“Plasma processing is a superior method for the microbial remediation of heat- and radiation-sensitive products, such as cannabis flower,” adds Dr. Florina Truica, Chief Technology Officer (CTO) of CPG. “Without ionizing radiation, heat, or chemicals, it better protects the quality of the final product. The current commercial implementation for the cannabis sector and the launch of ‘smart’ plasma sterilizers is just the beginning for us. CPG is developing additional plasma solutions for the medical or agriculture sectors. Our technology reduces the consumption of energy and chemicals, eliminates toxic by-products, and is overall safer for people and the environment.”
Stefan Langer, Chief Business Development (CBD), GOC-NEXUS observes of the technology: “We were searching for sterilization options that do not suffer from the quality and regulatory issues faced by existing sterilization options. Cold Plasma is the missing link in the design and construction of service hubs for cannabis processing, first for Europe, then globally. We have a tight timeline for both the Canadian demo-hub and our first large-scale European hub.”
For more information:
Cold Plasma Group
hello@coldplasmagroup.ca
coldplasmagroup.ca
GOC-NEXUS
www.goc-nexus.com